Oncopeptides AB: Oncopeptides publishes Q3 2021 report : com

Back to the future STOCKHOLM, Nov. 24, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat

Related Keywords

Sweden , Stockholm , United Kingdom , Martyj Duvall , Anders Martin , Annika Muskantor , Rolf Gulliksen , Linda Holmstr , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Oncopeptide Leadership , Global Head , Corporate Communications , Investor Relations , Abuse Regulation , Securities Markets , Corporate Headquarters , Mid Cap , Oncopeptides , Ublishes , 021 , Report ,